Introduction: Frontotemporal lobar degeneration (FTLD) is the second most abundant form of presenile dementia. 60% of FTLD patients are pathologically characterized by ubiquitin-and TAR-DNA binding protein 43-positive nuclear or cytoplasmic inclusions (FTLD-TDP). Genetic linkage studies and/or mutation screenings identified loss-of-function mutations in the progranulin gene (GRN) in patients with familial FTLD-TDP, which results in a severe reduction of GRN levels in tissues and biological fluids of patients. Additionally, missense mutations lead due to missorting, degradation and probably misfolding to reduced secretion of GRN. Since GRN is known to have neurotrophic properties these findings strongly indicate that GRN haploinsufficiency is causally linked to neurodegeneration Aims: We searched for compounds that are capable of stimulating GRN production.
